Simeprevir, also known as TMC43, is a drug for the treatment and cure of hepatitis C. In the United States, simeprevir is approved by the Food and Drug Administration for use in combination with peginterferon-alfa and ribavirin for hepatitis C and hepatitis B. Simeprevir has been approved in Japan for the treatment of chronic hepatitis C infection, genotype 1.
Raboisson, Pierre; de Kock, Herman; Rosenquist, Asa; Nilsson, Magnus; Salvador-Oden, Lourdes; Lin, Tse-I.; Roue, Natalie; Ivanov, Vladimir; Wahling, Horst; Wickstrom, Kristina; Hamelink, Elizabeth; Edlund, Michael; Vrang, Lotta; Vendeville, Sandrine; Van de Vreken, Wim; McGowan, David; Tahri, Abdellah; Hu, Lili; Boutton, Carlo; Lenz, Oliver; Delouvroy, Frederic; Pille, Geert; Surleraux, Dominique; Wigerinck, Piet; Samuelsson, Bertil; Simmen, Kenneth. Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350. Bioorganic & Medicinal Chemistry Letters. Volume 18 Issue 17. Pages 4853-4858. Journal. (2008).
Horvath, Andras; Depre, Dominique; A. Vermeulen, Wim A.; Wuyts, Stijn L.; Harutyunyan, Syuzanna R.; Binot, Gregori; Cuypers, Jef; Couck, Wouter; Den Heuvel, Dirk Van. Ring-Closing Metathesis on Commercial Scale: Synthesis of HCV Protease Inhibitor Simeprevir. Journal of Organic Chemistry. Volume 84. Issue 8. Pages 4932-4939. Journal; Online Computer File. (2019).
Depre, Dominique Paul Michel; Ormerod, Dominic John; Horvath, Andras; Moody, Thomas Shaw; Brossat, Maude; Riant, Olivier; Vriamont, Nicolas; Lemaire, Sebastien Francois Emmanuel; Hermant, Sebastien Nicolas J. Processes and intermediates for preparing Simeprevir, a macrocyclic protease inhibitor of HCV. Assignee Janssen Pharmaceuticals, Inc., USA. WO 2016157058. (2016).
Lin, Bangping; Li, Bin; Zhao, Hai; Du, Xiaodong; Yang, Jianjun. Process for preparation of HCV inhibitor. Assignee Sinochem Corporation, Peop. Rep. China; Sinochem Ningbo (Group) Co., Ltd. CN 101921269. (2010).
